Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 4
2005 6
2006 11
2007 10
2008 7
2009 5
2010 6
2011 11
2012 7
2013 4
2014 1
2015 4
2016 8
2017 9
2018 7
2019 8
2020 6
2021 4
2022 11
2023 4
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

110 results

Results by year

Filters applied: . Clear all
Page 1
How to define failure of intradetrusor injections of botulinum toxin A for neurogenic detrusor overactivity.
Mailho C, Peyronnet B, De Seze M, Even A, Perrouin-Verbe MA, Amarenco G, Chartier-Kastler E, Le Normand L, Manunta A, Karsenty G, Kerdraon J, Ruffion A, Saussine C, Le Breton F, Bernuz B, Castel-Lacanal E, Denys P, Phé V, Gamé X. Mailho C, et al. Among authors: denys p. Neurourol Urodyn. 2024 Apr;43(4):811-817. doi: 10.1002/nau.25427. Epub 2024 Mar 7. Neurourol Urodyn. 2024. PMID: 38451038 Review.
Intravesical injections of botulinum neurotoxin A to treat overactive bladder and/or detrusor overactivity related to multiple sclerosis: 5-Year continuation rate and specific risk factors for discontinuation-A study from the neuro-urology committee of the French Association of Urology.
Delaval S, Dequirez PL, Hentzen C, Baron M, Mille E, Tariel F, Peyronnet B, Perrouin-Verbe MA, Pierache A, Chartier-Kastler E, Capon G, Cornu JN, Castel-Lacanal E, Gamé X, Karsenty G, Ruffion A, Denys P, Even A, Joussain C, Amarenco G, Phé V, Biardeau X. Delaval S, et al. Among authors: denys p. Mult Scler. 2023 Jul;29(8):1024-1032. doi: 10.1177/13524585231174580. Epub 2023 Jun 2. Mult Scler. 2023. PMID: 37264947
AbobotulinumtoxinA is effective in patients with urinary incontinence due to neurogenic detrusor overactivity regardless of spinal cord injury or multiple sclerosis etiology: Pooled analysis of two phase III randomized studies (CONTENT1 and CONTENT2).
Denys P, Castaño Botero JC, Vita Nunes RL, Wachs B, Mendes Gomes C, Krivoborodov G, Tu LM, Del-Popolo G, Thompson C, Vilain C, Volteau M, Kennelly M; Dysport CONTENT program group. Denys P, et al. Neurourol Urodyn. 2023 Jan;42(1):153-167. doi: 10.1002/nau.25062. Epub 2022 Nov 2. Neurourol Urodyn. 2023. PMID: 36321799 Free PMC article. Clinical Trial.
Non-continent Urinary Diversion (Ileal Conduit) as Salvage Therapy in Patients With Refractory Lower Urinary Tract Dysfunctions due to Multiple Sclerosis: Results of a National Cohort From the French Association of Urology (AFU) Neurourology Committee and the French-speaking Neurourology Study Group (GENULF).
Chkir S, Michel F, Akakpo W, Chinier E, Capon G, Peyronnet B, Saussine C, Baron M, Biardeau X, Ruffion A, Gamé X, Denys P, Chartier-Kastler E, Phé V, Karsenty G. Chkir S, et al. Among authors: denys p. Urology. 2022 Oct;168:216-221. doi: 10.1016/j.urology.2022.06.014. Epub 2022 Jun 26. Urology. 2022. PMID: 35768028
Efficacy and Safety of AbobotulinumtoxinA in Patients with Neurogenic Detrusor Overactivity Incontinence Performing Regular Clean Intermittent Catheterization: Pooled Results from Two Phase 3 Randomized Studies (CONTENT1 and CONTENT2).
Kennelly M, Cruz F, Herschorn S, Abrams P, Onem K, Solomonov VK, Del Rosario Figueroa Coz E, Manu-Marin A, Giannantoni A, Thompson C, Vilain C, Volteau M, Denys P; Dysport CONTENT Program Group. Kennelly M, et al. Among authors: denys p. Eur Urol. 2022 Aug;82(2):223-232. doi: 10.1016/j.eururo.2022.03.010. Epub 2022 Apr 7. Eur Urol. 2022. PMID: 35400537 Free article. Clinical Trial.
110 results